Article Text

Download PDFPDF
Case report
Republished: Cortical blindness as a rare presentation of hemorrhagic cerebral hyperperfusion syndrome following vertebral angioplasty
  1. Chao Fu1,
  2. Zhongxin Xu2,
  3. Zhenzhen Hu3,
  4. Shuai Yao2,
  5. Fengmin Liu1,
  6. Baiqi Feng4,
  7. Conghai Zhao1,
  8. Weidong Yu1
  1. 1 Department of Neurosurgery, China-Japan Union Hospital of Jilin University, Changchun, China
  2. 2 Department of Neurology, China-Japan Union Hospital of Jilin University, Changchun, China
  3. 3 Department of Radiology, China-Japan Union Hospital of Jilin University, Changchun, China
  4. 4 Department of Neurosurgery, Qianguo County Hospital, Songyuan, China
  1. Correspondence to Dr Weidong Yu; fc616{at}


Cerebral hyperperfusion syndrome (CHS) is a well-documented complication after carotid endarterectomy or stenting. In contrast, CHS following vertebral revascularization is extremely rare. Here we present a case of a 77-year-old man with high-grade vertebral stenosis who subsequently underwent balloon angioplasty, complicated by hemorrhagic CHS manifesting as cortical blindness, although strict postoperative blood pressure control was administered. To our knowledge, cortical blindness as a presentation of hemorrhagic CHS has not previously been reported. This study highlights the fact that identifying high-risk patients, as well as making an individual therapeutic plan, is important prior to revascularization. Further studies are needed to elucidate the exact mechanism of this condition and thereby prevent it.

  • angioplasty
  • complication
  • stenosis

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Republished with permission from BMJ Case Reports Published 30 October 2017;doi: 10.1136/bcr-2017-013412

  • CF and ZX contributed equally.

  • Contributors CF, ZX, CZ, and WY diagnosed and treated the patient. CF, ZH, SY, BF, and WY designed the study, interpreted the data, and wrote the manuscript. CF, ZX, FL, CZ, and WY revised the manuscript.

  • Competing interests None declared.

  • Patient consent Obtained.

  • Ethics approval Ethics Committee of the China-Japan Union Hospital of Jilin University.

  • Provenance and peer review Not commissioned; externally peer reviewed.